Hot Pursuit     22-Apr-21
Panacea Biotec Ltd Spurts 9.92%, S&P BSE Healthcare index Rises 1.13%
Panacea Biotec Ltd has added 71.98% over last one month compared to 13.16% gain in S&P BSE Healthcare index and 5.63% drop in the SENSEX

Panacea Biotec Ltd rose 9.92% today to trade at Rs 323.5. The S&P BSE Healthcare index is up 1.13% to quote at 23652.02. The index is up 13.16 % over last one month. Among the other constituents of the index, Morepen Laboratories Ltd increased 6.8% and Astrazeneca Pharma India Ltd added 6.22% on the day. The S&P BSE Healthcare index went up 56.36 % over last one year compared to the 50.53% surge in benchmark SENSEX.

Panacea Biotec Ltd has added 71.98% over last one month compared to 13.16% gain in S&P BSE Healthcare index and 5.63% drop in the SENSEX. On the BSE, 54749 shares were traded in the counter so far compared with average daily volumes of 1.29 lakh shares in the past one month. The stock hit a record high of Rs 323.7 on 22 Apr 2021. The stock hit a 52-week low of Rs 109.17 on 22 Apr 2020.

Previous News
  Morepen Laboratories launches four new products for domestic market
 ( Corporate News - 24-Apr-25   16:13 )
  Morepen Lab jumps on plans to expand salesforce
 ( Hot Pursuit - 11-Apr-25   12:05 )
  Morepen Laboratories plans to add 1,000 medical representatives
 ( Corporate News - 11-Apr-25   09:16 )
  AstraZeneca Pharma gets CDSCO nod to import and distribute TAGRISSO (Osimertinib)
 ( Hot Pursuit - 05-Apr-25   14:43 )
  Morepen Lab gains after receiving Loratadine approval for export to China
 ( Hot Pursuit - 01-Apr-25   11:04 )
  Morepen Laboratories receives China NMPA approval for Loratadine
 ( Corporate News - 01-Apr-25   09:08 )
  Jyoti Structures Ltd leads gainers in 'A' group
 ( Hot Pursuit - 18-Mar-25   12:01 )
  Morepen Lab soars on launching Empamore to combat diabetes in India
 ( Hot Pursuit - 18-Mar-25   10:01 )
  Indices drift higher in early trade; breadth strong
 ( Market Commentary - Mid-Session 18-Mar-25   09:38 )
  Astrazeneca Pharma gains after receiving approval from CDSO to import Durvalumab solution.
 ( Hot Pursuit - 03-Mar-25   14:43 )
  Morepen Laboratories gains after arm incorporates new subsidiary
 ( Hot Pursuit - 19-Feb-25   14:42 )
Other Stories
  RBL Bank PAT drops 81% YoY to Rs 69 crore in Q4 FY25; provisions zoom by 90% YoY
  26-Apr-25   12:12
  Tejas Networks reports dismal Q4 outcome
  26-Apr-25   11:54
  Zydus Life gets 6 observations from USFDA for API plant
  26-Apr-25   11:02
  RIL Q4 PAT rises 6.4% YoY
  26-Apr-25   10:05
  Tata Technologies Q4 PAT climbs 12% QoQ to Rs 189 cr
  25-Apr-25   17:34
  VST Inds slides after Q4 PAT slumps 42% YoY to Rs 67 cr; declares dividend of Rs 10/sh
  25-Apr-25   15:45
  Atul gains after Q4 PAT soars 117% YoY; declares dividend of Rs 25/sh
  25-Apr-25   15:20
  Orient Electric Q4 PAT soars 144% YoY to Rs 31 crore
  25-Apr-25   15:20
  Oriental Hotels PAT rises 8% YoY in Q4 FY25
  25-Apr-25   15:05
  Maruti Suzuki records PAT of Rs 3,711.1 crore in Q4; Op. EBIT margin at 8.7%
  25-Apr-25   15:00
Back Top